• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体作为营养和能量代谢的核受体。

PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.

机构信息

Beijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

Key Laboratory for Cell Proliferation and Regulation Biology of State Education Ministry, College of Life Sciences, Beijing Normal University, Beijing 100875, China.

出版信息

Molecules. 2019 Jul 12;24(14):2545. doi: 10.3390/molecules24142545.

DOI:10.3390/molecules24142545
PMID:31336903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6680900/
Abstract

It has been more than 36 years since peroxisome proliferator-activated receptors (PPARs) were first recognized as enhancers of peroxisome proliferation. Consequently, many studies in different fields have illustrated that PPARs are nuclear receptors that participate in nutrient and energy metabolism and regulate cellular and whole-body energy homeostasis during lipid and carbohydrate metabolism, cell growth, cancer development, and so on. With increasing challenges to human health, PPARs have attracted much attention for their ability to ameliorate metabolic syndromes. In our previous studies, we found that the complex functions of PPARs may be used as future targets in obesity and atherosclerosis treatments. Here, we review three types of PPARs that play overlapping but distinct roles in nutrient and energy metabolism during different metabolic states and in different organs. Furthermore, research has emerged showing that PPARs also play many other roles in inflammation, central nervous system-related diseases, and cancer. Increasingly, drug development has been based on the use of several selective PPARs as modulators to diminish the adverse effects of the PPAR agonists previously used in clinical practice. In conclusion, the complex roles of PPARs in metabolic networks keep these factors in the forefront of research because it is hoped that they will have potential therapeutic effects in future applications.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 最初被发现能够增强过氧化物酶体增殖,距今已有 36 多年。因此,不同领域的许多研究表明,PPARs 是核受体,参与营养和能量代谢,并在脂质和碳水化合物代谢、细胞生长、癌症发展等过程中调节细胞和全身能量稳态。随着人类健康面临的挑战不断增加,PPARs 因其改善代谢综合征的能力而备受关注。在我们之前的研究中,我们发现 PPARs 的复杂功能可能被用作肥胖和动脉粥样硬化治疗的未来靶点。在这里,我们综述了三种类型的 PPARs,它们在不同代谢状态和不同器官中的营养和能量代谢中发挥重叠但又不同的作用。此外,研究还表明,PPARs 在炎症、中枢神经系统相关疾病和癌症中也发挥着许多其他作用。越来越多的药物开发基于使用几种选择性 PPAR 作为调节剂来减少以前在临床实践中使用的 PPAR 激动剂的不良反应。总之,PPARs 在代谢网络中的复杂作用使这些因素成为研究的前沿,因为人们希望它们在未来的应用中具有潜在的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee32/6680900/fc3daee50220/molecules-24-02545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee32/6680900/dd43c7f72052/molecules-24-02545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee32/6680900/fc3daee50220/molecules-24-02545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee32/6680900/dd43c7f72052/molecules-24-02545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee32/6680900/fc3daee50220/molecules-24-02545-g002.jpg

相似文献

1
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.过氧化物酶体增殖物激活受体作为营养和能量代谢的核受体。
Molecules. 2019 Jul 12;24(14):2545. doi: 10.3390/molecules24142545.
2
Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.过氧化物酶体增殖物激活受体 (PPARs)及其信号级联在细胞和全身能量稳态中的关键作用。
Int J Mol Sci. 2018 Mar 22;19(4):949. doi: 10.3390/ijms19040949.
3
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.合成及天然过氧化物酶体增殖物激活受体(PPAR)激动剂作为代谢综合征的治疗候选药物。
Expert Opin Ther Targets. 2017 Mar;21(3):333-348. doi: 10.1080/14728222.2017.1280467. Epub 2017 Jan 25.
4
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.关于通过调节脂质感应核受体来调控能量代谢的食物衍生因子的研究综述。
Biosci Biotechnol Biochem. 2019 Apr;83(4):579-588. doi: 10.1080/09168451.2018.1559025. Epub 2018 Dec 20.
5
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.过氧化物酶体增殖物激活受体(PPARs)在代谢稳态失调、炎症和癌症中的多效性作用:当前证据与未来展望
Int J Mol Sci. 2016 Jun 24;17(7):999. doi: 10.3390/ijms17070999.
6
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.药物洞察:过氧化物酶体增殖物激活受体激动剂的作用机制及治疗应用
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397.
7
PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.过氧化物酶体增殖物激活受体(PPARs)在脂肪组织中的代谢稳态调控。
Int J Mol Sci. 2021 Aug 20;22(16):8974. doi: 10.3390/ijms22168974.
8
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.过氧化物酶体增殖物激活受体在病理性心肌肥大和心力衰竭中的作用
Curr Pharm Des. 2017;23(11):1677-1686. doi: 10.2174/1381612822666160928150040.
9
Targeting PPARs for therapy of atherosclerosis: A review.靶向过氧化物酶体增殖物激活受体治疗动脉粥样硬化:综述。
Int J Biol Macromol. 2023 Jul 1;242(Pt 2):125008. doi: 10.1016/j.ijbiomac.2023.125008. Epub 2023 May 20.
10
Biology and therapeutic applications of peroxisome proliferator- activated receptors.过氧化物酶体增殖物激活受体的生物学和治疗应用。
Curr Top Med Chem. 2012;12(6):548-84. doi: 10.2174/156802612799436669.

引用本文的文献

1
Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.健康与疾病中的核受体:信号通路、生物学功能及药物干预
Signal Transduct Target Ther. 2025 Jul 28;10(1):228. doi: 10.1038/s41392-025-02270-3.
2
Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death.过氧化物酶体增殖物激活受体δ(PPARδ)的药理学抑制可导致选择性白血病细胞死亡。
Cancer Metab. 2025 Jul 25;13(1):36. doi: 10.1186/s40170-025-00402-5.
3
Effects of Docosahexaenoic Acid on Prostate Cancer.

本文引用的文献

1
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.在伴有肾功能损害的血脂异常患者中,新型选择性过氧化物酶体增殖物激活受体-α调节剂(SPPARMα)——帕马溴的长期疗效和安全性。
Int J Mol Sci. 2019 Feb 6;20(3):706. doi: 10.3390/ijms20030706.
2
Interactions between Host PPARs and Gut Microbiota in Health and Disease.宿主 PPAR 与肠道微生物群在健康与疾病中的相互作用。
Int J Mol Sci. 2019 Jan 17;20(2):387. doi: 10.3390/ijms20020387.
3
Fasting Imparts a Switch to Alternative Daily Pathways in Liver and Muscle.
二十二碳六烯酸对前列腺癌的影响。
J Xenobiot. 2025 Jul 4;15(4):111. doi: 10.3390/jox15040111.
4
Transcription Factors and Methods for the Pharmacological Correction of Their Activity.转录因子及其活性的药理学校正方法。
Int J Mol Sci. 2025 Jul 2;26(13):6394. doi: 10.3390/ijms26136394.
5
A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes.黄芪甲苷和小檗碱对肥胖及糖尿病相关血管功能障碍作用机制的研究综述
Drug Des Devel Ther. 2025 Jun 7;19:4911-4932. doi: 10.2147/DDDT.S520323. eCollection 2025.
6
Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.过氧化物酶体增殖物激活受体(PPARs)可能介导益生菌代谢产物的神经活性作用:一种计算机模拟方法
Int J Mol Sci. 2025 May 9;26(10):4507. doi: 10.3390/ijms26104507.
7
Bilirubin metabolism and its application in disease prevention: mechanisms and research advances.胆红素代谢及其在疾病预防中的应用:机制与研究进展
Inflamm Res. 2025 May 24;74(1):81. doi: 10.1007/s00011-025-02049-w.
8
Chikungunya Replication and Infection Is Dependent upon and Alters Cellular Hexosylceramide Levels in Vero Cells.基孔肯雅病毒的复制和感染依赖于并改变了非洲绿猴肾细胞中的神经酰胺水平。
Viruses. 2025 Mar 31;17(4):509. doi: 10.3390/v17040509.
9
Repositioning Perindopril for Mitigation of Methotrexate-Induced Hepatotoxicity in Rats.重新定位培哚普利以减轻大鼠甲氨蝶呤诱导的肝毒性
Pharmaceuticals (Basel). 2025 Mar 2;18(3):358. doi: 10.3390/ph18030358.
10
and : Paragons of Probiotic Potential and Reservoirs of Novel Antimicrobials.以及:益生菌潜力的典范和新型抗菌剂的储存库。
Microorganisms. 2025 Feb 28;13(3):555. doi: 10.3390/microorganisms13030555.
禁食赋予肝脏和肌肉替代的日常途径。
Cell Rep. 2018 Dec 18;25(12):3299-3314.e6. doi: 10.1016/j.celrep.2018.11.077.
4
Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.吡格列酮可改善肠易激综合征大鼠模型的内脏感觉和结肠通透性。
J Pharmacol Sci. 2019 Jan;139(1):46-49. doi: 10.1016/j.jphs.2018.11.006. Epub 2018 Nov 24.
5
Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue.过氧化物酶体增殖物激活受体 (PPAR)γ 激动剂作为肿瘤组织的主要调节剂。
Int J Mol Sci. 2018 Nov 9;19(11):3540. doi: 10.3390/ijms19113540.
6
The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor.过氧化物酶体增殖物激活受体-δ(PPAR-δ)在代谢、炎症和癌症中的作用:作为关键转录因子的多面性。
Int J Mol Sci. 2018 Oct 26;19(11):3339. doi: 10.3390/ijms19113339.
7
Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells.荷叶碱通过 LPS 诱导的 RAW264.7 细胞中的 PPARs 抑制促炎细胞因子。
Molecules. 2018 Oct 22;23(10):2723. doi: 10.3390/molecules23102723.
8
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development.过氧化物酶体增殖物激活受体配体在临床药物研发中的机遇与挑战。
Int J Mol Sci. 2018 Jul 27;19(8):2189. doi: 10.3390/ijms19082189.
9
PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity.过氧化物酶体增殖物激活受体(PPARs)与脂肪组织可塑性障碍相关的代谢紊乱。
Int J Mol Sci. 2018 Jul 21;19(7):2124. doi: 10.3390/ijms19072124.
10
Molecular Actions of PPARα in Lipid Metabolism and Inflammation.PPARα 在脂质代谢和炎症中的分子作用。
Endocr Rev. 2018 Oct 1;39(5):760-802. doi: 10.1210/er.2018-00064.